The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1250 Weight Loss articles
Severe ankle pain led Jelon Smart to Ozempic, where she dropped 30 pounds quickly—but plateaued until adding exercise. Doctors like Dafina Allen and Gerald Onuoha stress that GLP-1s alone aren't enough; movement, mental health, and monitored dosing are key for long-term success and safety.
A groundbreaking phase 3 trial shows orforglipron, a new daily oral weight-loss pill, surpassing oral semaglutide in blood sugar control and weight reduction for type 2 diabetes patients. This small-molecule GLP-1 agonist offers advantages over injectables like Ozempic by eliminating needles and refrigeration needs. However, higher gastrointestinal side effects raise questions about long-term tolerability.
More people are using GLP-1 injectables like Wegovy for weight management, but air travel poses refrigeration challenges. As a flight attendant, I've fielded countless requests to store meds in plane fridges—here's why that's not possible and the practical solutions that work.
Wondering what happens to your body when you take Ozempic without exercising? A recent study in Sports Medicine analyzed liraglutide users and found that while GLP-1 drugs promote weight loss, skipping exercise leads to poorer fitness outcomes. Exercise plus the drug delivers the best results for health and function.
Boston Mayor Michelle Wu announced a deal with unions to implement prior authorization for GLP-1 weight loss drugs like Ozempic and Wegovy, saving the city $10.6 million. This move addresses skyrocketing health costs that threatened 22.6% premium hikes. City workers must now get approval for coverage on these popular obesity treatments.
Amid the GLP-1 boom driving med-spas and weight loss clinics, VITL has landed $7.5M in Series A funding to revolutionize e-prescribing for cash-pay providers. The platform slashes prescription times to seconds with real-time pricing and tracking from compounding pharmacies. With 630 clinics onboard and eight-figure ARR, VITL is poised to scale in the growing peptide and aesthetic market.
The FDA just greenlit a groundbreaking higher dose of Wegovy, tripling the previous maximum to 7.2 milligrams for enhanced weight management. Patients saw up to 21% body weight loss, with unique cardiovascular protections. Here's what this means for obesity treatment and access.
GLP-1 medications are suppressing appetite, prompting users to prioritize protein quality over quantity—and dairy is ideally positioned to meet this demand, says Valio's innovation chief Dr. Kevin Deegan. At the Arena Dairy Innovation Strategies conference, experts discussed how these drugs change consumer perceptions of protein and sweetness. While some users revert to old habits post-treatment, dairy's natural, high-quality proteins offer a strategic advantage.
Lawsuits against Ozempic manufacturer Novo Nordisk are exploding in the US, with patients alleging the company hid severe side effects like gastroparesis and sudden vision loss from semaglutide. Originally a type 2 diabetes drug, Ozempic's popularity as a weight loss shot has sparked debates on safety and marketing. Despite high demand, experts urge medical supervision to avoid serious risks.
